-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Gt/+PAaMlNbMLw9jCBDkmQL0We/HIb292hv6F6R8jSE3xjjtT4P9RZSyXJOx7yzu RxW4uI8qvd+wIIhviRvOjA== 0001104659-05-055917.txt : 20051115 0001104659-05-055917.hdr.sgml : 20051115 20051115170116 ACCESSION NUMBER: 0001104659-05-055917 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20051115 DATE AS OF CHANGE: 20051115 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAIN CAPITAL EUROPE LLC CENTRAL INDEX KEY: 0001231570 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: C/O BAIN CAPITAL LTD STREET 2: DEVONSHIRE HOUSE MAYFAIR PLACE CITY: LONDON ENGLAND STATE: A1 ZIP: W1JSAJ BUSINESS PHONE: 442075145252 MAIL ADDRESS: STREET 1: DEVOSHIRE HOUSE MAYFAIR PLACE CITY: LONDON ENGLAND STATE: A1 ZIP: 1JI3AI SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SAMSONITE CORP/FL CENTRAL INDEX KEY: 0000914478 STANDARD INDUSTRIAL CLASSIFICATION: LEATHER & LEATHER PRODUCTS [3100] IRS NUMBER: 363511556 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-47327 FILM NUMBER: 051207321 BUSINESS ADDRESS: STREET 1: 11200 EAST 45TH AVENUE CITY: DENVER STATE: CO ZIP: 80239 BUSINESS PHONE: 3033732000 MAIL ADDRESS: STREET 1: 11200 EAST 45TH AVENUE CITY: DENVER STATE: CO ZIP: 80239 FORMER COMPANY: FORMER CONFORMED NAME: ASTRUM INTERNATIONAL CORP DATE OF NAME CHANGE: 19931105 SC 13D/A 1 a05-19976_1sc13da.htm AMENDMENT

 

 

UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE
COMMISSION

OMB Number:
3235-0145

 

Washington, D.C. 20549

Expires: December 31, 2005

 

SCHEDULE 13D

Estimated average burden hours per response. . 11

Under the Securities Exchange Act of 1934
(Amendment No.  8)*

SAMSONITE CORPORATION

(Name of Issuer)

 

COMMON STOCK

(Title of Class of Securities)

 

79604V105

(CUSIP Number)

 

James L. Learner, P.C.

Kirkland & Ellis International LLP

Tower 42

25 Old Broad Street

London EC2N 1HQ

United Kingdom

Telephone Number:  +44 (0) 20 7816 8700

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

November 14, 2005

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 



 

CUSIP No.   79604V105

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Bain Capital (Europe) LLC

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 ý

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
AF

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
State of Delaware, United States of America

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
156,179,922 (see item 5)

 

8.

Shared Voting Power 
0

 

9.

Sole Dispositive Power 
156,179,922 (see item 5)

 

10.

Shared Dispositive Power 
0

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person 
156,179,922 (see item 5)

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11) 
43.5%

 

 

14.

Type of Reporting Person (See Instructions)
OO

 

 

2



 

Item 1.

Security and Issuer

 

Item 1 is hereby amended to add the following:

 

This Amendment No. 8 supplements and amends the initial statement on Schedule 13D dated May 9, 2003 (the “Initial Statement”), Amendment No. 1 to the Initial Statement dated August 6, 2003 (“Amendment No. 1”), Amendment No. 2 to the Initial Statement dated August 28, 2003 (“Amendment No. 2”), Amendment No. 3 to the Initial Statement dated September 30, 2003 (“Amendment No. 3”), Amendment No. 4 to the Initial Statement dated April 27, 2004 (“Amendment No. 4”), Amendment No. 5 to the Initial Statement dated July 20, 2004 (“Amendment No. 5”), Amendment No. 6 to the Initial Statement dated October 22, 2004 (“Amendment No. 6”), and Amendment No. 7 to the Initial Statement dated January 5, 2005 (“Amendment No. 7”) filed by the Reporting Person. The principal executive offices of the Issuer are located at 11200 East 45th Avenue, Denver, CO 80239.  This Amendment No. 8 (this “Amendment”) to Schedule 13D relates to the Common Stock, par value $0.01 per share (“Common Stock”), the convertible Preferred Stock, par value of $0.01 per share (“Preferred Stock”), and warrants, exercisable in exchange for 11.194 shares of Common Stock (the “Warrants”), of Samsonite Corporation, a corporation incorporated under the laws of the State of Delaware (the “Issuer”). The Preferred Stock is convertible on demand into shares of Common Stock and holders of Preferred Stock may vote their Preferred Stock on an as-converted basis. The Warrants are currently convertible into Common Stock at the exercise price of $13.02 per share.

 

 

Item 2.

Identity and Background

 

Item 2 is hereby deleted in its entirety and replaced as follows:

 

This Amendment is filed by Bain Capital (Europe) LLC, a limited liability company organized under the laws of the State of Delaware (the “Reporting Person”).  The Reporting Person was formed for the object and purpose of, and the nature of the business to be conducted and promoted by the Reporting Person is, engaging in any lawful act or activity for which limited liability companies may be formed under the Delaware Limited Liability Company Act (6 Del.C. § 18-101, et seq.) (the “Act”), as amended from time to time, and engaging in any and all activities necessary or incidental to the foregoing.  The current principal business address of the Reporting Person is Devonshire House, Mayfair Place, London, England W1J8AJ.

 

Bain Capital Investors, LLC, a limited liability company organized under the laws of the State of Delaware, is the sole “manager” (as that term is used in the Act) of the Reporting Person, with the title of “Manager.” Bain Capital Investors, LLC was formed for the object and purpose of, and the nature of the business to be conducted and promoted by the Manager is, engaging in any lawful act or activity for which limited liability companies may be formed under the Act, as amended from time to time, and engaging in any and all activities necessary or incidental to the foregoing.  The current principal business address of Bain Capital Investors, LLC is at c/o Bain Capital, LLC, 111 Huntington Avenue, Boston, MA 02199.

 

During the last five years, neither the Reporting Person, the Manager nor, to the knowledge of the Reporting Person, any of the persons listed on Schedules A and B to this Statement (i) has been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors) nor (ii) has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 3.

Source and Amount of Funds or Other Consideration

 

Item 3 is hereby amended to add the following:

 

The Reporting Person, pursuant to a Purchase Agreement (the “November 14, 2005 Purchase Agreement”) dated November 14, 2005 by and between the Reporting Person and Aram Ervin Kalpakian, Alicia Hurmuzian de Kalpakian, and Delfina Isabel Balestra (together, “Kalpakian”), on November 14, 2005 purchased 66 shares of Preferred Stock from Kalpakian for an aggregate consideration equal to $79,126.83, which was obtained by the Reporting Person through equity capital contributions made to the Reporting Person by certain of its members.

Item 4.

Purpose of Transaction

 

Item 4 is hereby amended to add the following:

 

Pursuant to the November 14, 2005 Purchase Agreement, the Reporting Person purchased, for investment purposes, 66 shares of Preferred Stock from Kalpakian for an aggregate consideration equal to $79,126.83.

 

As of the date hereof, the Reporting Person does not have any plan or proposal that relates to or would result in:

 

(i)               The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;

 

(ii)            An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;

 

(iii)         A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;

 

(iv)        Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;

 

(v)           Any material change in the present capitalization or dividend policy of the Issuer;

 

(vi)        Any other material change in the Issuer’s business or corporate structure;

 

(vii)     Changes in the Issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person;

 

(viii)  Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;

 

(ix)          A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or

 

(x)             Any action similar to any of those enumerated above.

 

Notwithstanding the foregoing, the Reporting Person may determine to change its investment intent with respect to the Issuer at any time in the future. In determining from time to time whether to sell its Warrants or shares of the Issuer’s Preferred Stock or Common Stock (and in what amounts) or to retain such Warrants and shares, the Reporting Person will take into consideration such factors as they deem relevant, including the business and prospects of the Issuer, anticipated future developments concerning the Issuer, existing and anticipated market conditions from time to time, general economic conditions, regulatory matters, and other opportunities available to the Reporting Person. The Reporting Person reserves the right to acquire additional securities of the Issuer in the open market, in privately negotiated transactions (which may be with the Issuer or with third parties) or otherwise, to dispose of all or a portion of their holdings of securities of the Issuer or to change their intention with respect to any or all of the matters referred to in this Item 4.  Also, consistent with their investment intent, the Reporting Person has engaged in and continues to engage in communications with one or more stockholders of the Issuer, one or more officers of the Issuer and/or one or more members of the board of directors of the Issuer regarding the Issuer, including but not limited to its operations.

 

 

Item 5.

Interest in Securities of the Issuer

 

Item 5 is hereby deleted in its entirety and replaced as follows:

 

(a) - (b)       The Reporting Person beneficially owns and has sole power to vote and sole power of disposition over 156,179,922 shares of Common Stock of the Issuer, or approximately 43.5 % of the Issuer’s outstanding Common Stock (based upon 227,159,626 shares of Common Stock reported by the Issuer on September 14, 2005 to be outstanding on September 9, 2005) through its ownership of (i) 24,477,118 shares of Common Stock, (ii) 46,119 shares of convertible Preferred Stock and interest accrued thereon (as at November 14, 2005), convertible into an aggregate of 131,646,834 shares of Common Stock, which is calculated by dividing the face value and accrued dividends on the Preferred Stock, through November 14, 2005, by the conversion price of the Preferred Stock, which is $0.42, and (iii) 5,000 Warrants, exercisable for 55,970 shares of Common Stock in exchange for payment of $13.02 per share of Common Stock.

 

(c)                                Except as set forth in Item 4 above, since the most recent filing of Schedule 13D by the Reporting Person there have been no reportable transactions by the Reporting Person with respect to the Common Stock of the Issuer.

 

(d) - (e)       Not applicable.

 

 

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

 

Item 6 is hereby amended to add the following:

 

Bain Capital (Europe) LLC entered into a Purchase Agreement dated November 14, 2005 with Aram Ervin Kalpakian, Alicia Hurmuzian de Kalpakian, and Delfina Isabel Balestra (together, “Kalpakian”), pursuant to which Bain Capital (Europe) LLC purchased 66 shares of Preferred Stock from Kalpakian for an aggregate consideration equal to $79,126.83.

 

Bain Capital (Europe) LLC, along with Samsonite Corporation, Ares Corporate Opportunities Fund, L.P., and Ontario Teachers’ Pension Plan Board, acknowledged a letter dated November 14, 2005 from Kalpakian, pursuant to which, among other things, Kalpakian agreed to indemnify and hold Bain Capital (Europe) LLC harmless against any losses, claims, damages, expenses, or liabilities to any person or entity arising out of or in connection with any breach of a representation or warranty made by Kalpakian under the November 14, 2005 Purchase Agreement.

 

 

Item 7.

Material to Be Filed as Exhibits

 

Item 7 is hereby amended to add the following:

 

Exhibit 11

Purchase Agreement, dated November 14, 2005, by and between Bain Capital (Europe) LLC and Kalpakian.

 

Exhibit 12

Letter Agreement dated November 14, 2005 from Kalpakian to Samsonite Corporation, Ares Corporate Opportunities Fund, L.P., Bain Capital (Europe) LLC, and Ontario Teachers’ Pension Plan Board.

 

3



 

SCHEDULE A

 

OFFICERS OF BAIN CAPITAL (EUROPE), LLC

 

Name

 

Title

 

 

 

Dwight M. Poler (1),(2)

 

President

 

 

 

Ferdinando Grimaldi Quartieri (1,3)

 

Vice President

 

 

 

Melissa Wong Bethell (1,2)

 

Vice President

 

 

 

Michael Colato (1,4)

 

Secretary

 


(1)                                  The current principal business address of each officer of the Reporting Person is c/o Bain Capital (Europe), LLC, Devonshire House, Mayfair Place, London, England W1J8AJ.

 

(2)           Dwight M. Poler and Melissa Wong Bethell are citizens of the United States of America.

 

(3)                                  Ferdinando Grimaldi Quartieri is a citizen of Italy.

 

(4)                                  Michael Colato is a citizen of the United Kingdom.

 

4



 

SCHEDULE B

 

OFFICERS OF BAIN CAPITAL INVESTORS, LLC.

 

Name

 

Title

 

 

 

 

 

Richard C. Albright

 

Managing Director

 

 

 

 

 

Andrew Balson

 

Managing Director

 

 

 

 

 

Steve Barnes

 

Managing Director

 

 

 

 

 

Joshua Bekenstein

 

Managing Director

 

 

 

 

 

Edward W. Conard

 

Managing Director

 

 

 

 

 

John P. Connaughton

 

Managing Director

 

 

 

 

 

Paul B. Edgerley

 

Managing Director

 

 

 

 

 

Michael F. Goss

 

Managing Director/Chief Financial Officer/
Secretary

 

 

 

 

 

Matthew S. Levin

 

Managing Director

 

 

 

 

 

Ian Loring

 

Managing Director

 

 

 

 

 

Phil Loughlin

 

Managing Director

 

 

 

 

 

Mark E. Nunnelly

 

Managing Director

 

 

 

 

 

Stephen G. Pagliuca

 

Managing Director

 

 

 

 

 

Dwight M. Poler

 

Managing Director

 

 

 

 

 

Stephen M. Zide

 

Managing Director

 

 


(1)                                  The current principal business address of each officer of Bain Capital Investors, LLC is c/o Bain Capital, LLC, 111 Huntington Avenue, Boston, MA, 02199.

 

(2)                                  Each of the officers is a citizen of the United States of America.

 

5



 

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

November 15, 2005

 

Date

 

 

 

Bain Capital (Europe) LLC
/s/ Melissa Wong Bethell

 

Signature

 

 

 

Melissa Wong Bethell / Vice President

 

Name/Title

 

6


EX-11 2 a05-19976_1ex11.htm PURCHASE AGREEMENT

Exhibit 11

 

PURCHASE AGREEMENT

 

This purchase agreement (the “Agreement”) is entered into this 14th day of November, 2005, by and between Aram Ervin Kalpakian, Alicia Hurmuzian de Kalpakian and Delfina Isabel Balestra (“Seller”) and Bain Capital (Europe) LLC, (“Purchaser”), with reference to the following facts:

 

R E C I T A L S

 

WHEREAS, Seller currently owns 198 shares of the convertible preferred stock, par value $.01 per share (the “Preferred Stock”) of Samsonite Corporation (the “Company”);

 

WHEREAS, in accordance with the Stockholders Agreement of July 31, 2003 between affiliates of the Purchaser and the Company, affiliates of the Purchaser currently serve as members of the Board of Directors of the Company;

 

WHEREAS, Purchaser and its affiliates hold a significant portion of the issued and outstanding Preferred Stock of the Company as well as a significant amount of the common stock, par value $0.01 per share, of the Company;

 

WHEREAS, Purchaser may have access to and/or be in possession of material, nonpublic, confidential information regarding the Company and its subsidiaries and/or its affiliates, including without limitation its financial condition, results of operations, businesses, properties, assets, liabilities, management, projections, appraisals, plans (including without limitation potential acquisitions and sales of assets and debt and equity financing activities) and prospects (collectively, the “Information”); and

 

WHEREAS, Seller desires to sell and Purchaser desires to purchase sixty-six (66) shares of the Preferred Stock (such shares of the Preferred Stock being referred to as the “Purchased Shares”) upon the terms and subject to the conditions set forth in this Agreement;

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

 

1.             Purchase and Sale of Purchased Shares.

 

1.1           Purchase and Sale.  Subject to the fulfillment of the conditions precedent set forth in Section 1.4 below, on the Settlement Date (as defined below), Seller will sell, transfer and assign to Purchaser, and Purchaser will purchase from Seller, all of Seller’s right, title and interest in the Purchased Shares, free and clear of any lien, pledge, or encumbrance of any kind.  In connection therewith, Seller shall deliver stock certificates covering the Purchased Shares duly executed in blank to Purchaser or in accordance with Purchaser’s instructions.

 

1



 

1.2           Purchase Price.  The purchase price to be paid by Purchaser to Seller for the Purchased Shares is $79,126.83 ($1,000.00 liquidation preference for each Purchased Share plus accrued dividends thereon).  The purchase price shall be paid on the Settlement Date by wire transfer to an account to be designated by Seller.

 

1.3           Settlement Date. The settlement date shall be November 14, 2005 (“the Settlement Date”) in accordance with this Agreement, and the settlement shall occur at such time and place as mutually agreed upon between Purchaser and Seller.

 

1.4           Conditions to SettlementThe obligations of each party to this Agreement are subject to the representations and warranties of the other party contained herein being true and correct on and as of the Settlement Date with the same effect as though such representations and warranties had been made on and as of the Settlement Date.

 

2.             Representations and Warranties of Seller.  Seller hereby represents and warrants to Purchaser as follows:

 

2.1           Due Execution, Delivery and Performance by Seller.  Seller has full right, power and authority to enter into this Agreement and perform the transactions contemplated hereby.  No consent, approval, authorization or other order of any court, regulatory body, administrative agency or other governmental body is required for the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby, and the execution, delivery and performance of this Agreement will not violate any judgment, order or decree to which Seller is subject on the Settlement Date.

 

2.2           Title to Securities.  Seller is the sole legal and beneficial owner of the Purchased Shares free and clear of any lien, pledge or encumbrance of any kind.

 

2.3           Authorization and Enforceability. This Agreement has been duly authorized, executed and delivered by Seller and, assuming the due authorization, execution and delivery by Seller, is the legal, valid and binding obligation of Seller, enforceable against Seller in accordance with its terms.

 

2.4           No Other Representations and Warranties. Seller does not make any representation or warranty to the Purchaser, whether express or implied, with respect to Purchased Shares, other than those specifically provided for in this Section 2.  Without limiting the generality of the foregoing, Seller does not make any representation or warranty to Purchaser with respect to the future profitability of the Purchased Shares or the financial performance of the Company.

 

3.             Other Acknowledgements and Agreements of Seller.  Seller hereby acknowledges and agrees that:

 

3.1           No Disclosure.  This Agreement shall not be deemed to create any contractual duty to disclose any Information.  Seller acknowledges and agrees that (i) Purchaser currently may have access to and/or be in the possession of, and later may come into possession of, Information that is not known to Seller and that may be material to a decision to sell the Purchased Shares, (ii) Purchaser has no duty (fiduciary or otherwise) to disclose to Seller any of the Information, (iii)  Seller has determined to sell the Purchased Shares on the terms and conditions set forth herein notwithstanding its lack of knowledge of the Information and

 

2



 

notwithstanding that such Information, if known to Seller, might affect the price at which Seller would be willing to sell the Purchased Shares, (iv) Seller has not requested and will not request from Purchaser any of the Information Purchaser may now have or of which Purchaser may later come into possession, (v) Seller has not relied in any way upon any act, statement or omission of Purchaser with respect to the Company, any of its subsidiaries, any of its affiliates or the Purchased Shares, (vi) Seller is experienced, sophisticated and knowledgeable in trading in securities of private and public companies and understands the disadvantage to which it is subject on account of the disparity of information between Purchaser and Seller and (vii) Seller has conducted its own investigation, to the extent that it has determined necessary or desirable regarding the Company, and Seller has determined to enter into and complete the sale of the Purchased Shares based on, among other things, such investigation.

 

3.2           Waiver and Release.  (a) Effective as of the closing on the Settlement Date, Seller, on its own behalf and on behalf of its successors and/or assigns, hereby forever waives, releases, discharges and dismisses any and all claims, rights, causes of action, suits, obligations, debts, demands, liabilities, controversies, costs, expenses, fees, and/or damages of any kind (including without limitation any and all claims alleging violations of federal or state securities laws, common-law fraud or deceit, breach of fiduciary duty, negligence or otherwise), whether directly, derivatively, representatively or in any other capacity, against Purchaser, the Company, its subsidiaries or any of their respective affiliates (including without limitation any and all of its and their respective past, present and/or future directors, officers, shareholders, members, partners, employees, fiduciaries , agents and advisors, and each of their respective successors and assigns), in any way based upon, arising from, relating to or involving, directly or indirectly, the sale of the Purchased Shares and the non-disclosure of the Information (so long as such Information does not make false Purchaser’s representations or warranties contained in this Agreement) by Purchaser to Seller in connection thereto. In connection with the foregoing release, Seller specifically waives any and all protections afforded by California Civil Code Section 1542, which provides as follows:

 

A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.

 

Seller further hereby specifically waives any and all protections afforded by any state or federal statute or regulation that would, if enforced, have the effect of limiting the enforceability or effectiveness of the foregoing release or other foregoing provisions of this acknowledgment and agreement.

 

3



 

(b) Effective as of the closing on the Settlement Date, Purchaser, on its own behalf and on behalf of its successors and/or assigns, hereby forever waives, releases, discharges and dismisses any and all claims, rights, causes of action, suits, obligations, debts, demands, liabilities, controversies, costs, expenses, fees, and/or damages of any kind (including without limitation any and all claims alleging violations of federal or state securities laws, common-law fraud or deceit, breach of fiduciary duty, negligence or otherwise), whether directly, derivatively, representatively or in any other capacity, against Seller or any of their respective affiliates (including without limitation any and all of its and their respective past, present and/or future directors, officers, shareholders, members, partners, employees, fiduciaries, agents and advisors, and each of their respective successors and assigns), in any way based upon, arising from, relating to or involving, directly or indirectly, the purchase of the Purchased Shares and the non-sufficiency of the Information; provided, however, this section 3.2(b) shall not release Seller from (i) any failure of any of its representations and warranties set forth in Section 2.2 hereof to be true and correct or (ii) any defects in title to the Purchased Shares.  In connection with the foregoing release, Purchaser specifically waives any and all protections afforded by California Civil Code Section 1542, which provides as follows:

 

A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.

 

Purchaser further hereby specifically waives any and all protections afforded by any state or federal statute or regulation that would, if enforced, have the effect of limiting the enforceability or effectiveness of the foregoing release or other foregoing provisions of this acknowledgment and agreement.

 

4.             Representations and Warranties of Purchaser.  Purchaser hereby represents and warrants to Seller as follows:

 

4.1           Due Execution, Delivery and Performance by Purchaser. Purchaser has full right, power and authority to enter into this Agreement and perform the transactions contemplated hereby.  No consent, approval, authorization or other order of any court, regulatory body, administrative agency or other governmental body is required for the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby, and the execution, delivery and performance of this Agreement will not violate any contract, order or decree to which Purchaser is subject on the Settlement Date.

 

4.2           Sophisticated Purchaser.  Purchaser (i) is a sophisticated entity and, by reason of its business and financial experience, and the business and financial experience of its management, is able to bear any financial risks associated with the purchase of the Purchased Shares (including, without limitation, the total loss of the investment in the Purchased Shares), (ii) has adequate information to make an informed decision regarding the purchase of the Purchased Shares, (iii) has such knowledge and experience, and has made investments of a similar nature, so as to be aware of and understand the risks inherent in the purchase in the Purchased Shares, (iv) has independently, and without reliance upon Seller, and based on such information as Purchaser has deemed appropriate, made its own analysis and decision to purchase the Purchased Shares, (v) in entering into this Agreement, Purchaser has relied solely upon its own investigation and analysis of the Company, the Purchased Shares and the Information and Purchaser acknowledges that, except as provided in Section 2, neither Seller nor any of its affiliates, agents or representatives makes or has made any representation or warranty, either express or implied, as to the accuracy or completeness of any of the information reviewed by Purchaser or its directors, officers, employees, affiliates, controlling persons, agents or representatives, and (vi) is purchasing the Purchased Shares with investment intent and not with a view toward distribution.

 

4



 

4.3           Unregistered Securities Acknowledgment.  Purchaser understands that the Purchased Shares have not been registered under the Securities Act of 1933, as amended (the “Act”), and may not be sold in the United States except pursuant to an effective registration statement, or pursuant to a duly available exemption from such registration requirements.

 

4.4           Accredited Investor.  Purchaser is an “accredited investor” within the meaning of Regulation D promulgated under the Act.  Purchaser is buying the Preferred Shares for Purchaser’s own account and for investment, not as nominee or agent, and not with the view to or for resale in connection with the distribution thereof.

 

4.5           Authorization and Enforceability. This Agreement has been duly authorized, executed and delivered by Purchaser and, assuming the due authorization, execution and delivery by Seller, is the legal, valid and binding obligation of Purchaser, enforceable against Purchaser in accordance with its terms.

 

5.             Miscellaneous.

 

5.1           Further Assurances.  Following the execution of this Agreement, each party hereto shall, from time to time, at the requesting party’s cost and expense, execute and deliver such additional instruments, documents, conveyances or assurances and take such other commercially reasonable actions as reasonably have been requested by the other party hereto to confirm and assure the rights and obligations provided for in this Agreement, and render effective the consummation of the transactions contemplated hereby.

 

5.2           Governing Law.  This Agreement and the legal relations between the parties arising hereunder shall be governed by and interpreted in accordance with the laws of the State of New York applicable to agreements made and to be fully performed therein, without respect to the conflict of laws provisions thereof.

 

5.3           Counterparts.  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

5.4           Titles and Subtitles.  The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing, interpreting, implementing or enforcing this Agreement.

 

5.5           Recitals. The recitals to this Agreement are a part of this Agreement and are to be considered in construing, interpreting, implementing and enforcing this Agreement.

 

5.6           Entire Agreement.  Other than that Indemnity Letter by and among, inter alios, the parties hereto and the Company dated on or around the date hereof, this Agreement constitutes the entire agreement between the parties and supersedes all prior written or oral discussions or agreements among the parties hereto with respect to the subject matter hereof and contains the sole and entire agreement among the parties hereto with respect to the subject matter hereof.

 

5



 

5.7           Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any law, regulation, rule or public policy, all other terms and provisions of this Agreement shall nevertheless remain in full force and effect and any trier-of-fact shall interpret this Agreement in the valid, legal and enforceable manner that corresponds most closely to the original intentions of the parties.

 

5.8           Successors and Assigns.  The terms and conditions of this Agreement shall inure to the benefit of, and be binding upon, the respective successors and permitted assigns of the parties hereto.

 

5.9           Delivery by Facsimile.  This Agreement and any signed agreement or instrument entered into in connection thereto or contemplated thereby, and any amendments hereto or thereto, to the extent signed and delivered by means of a facsimile machine, shall be treated in all manner and respect as an original agreement or instrument and shall be considered to have the same binding legal effect as it were the original signed version thereof delivered in person.  At the request of any party hereto or to any such agreement or instrument, each other party hereto or thereto shall re-execute original forms thereof and deliver them to all other parties.  No party hereto or to any such agreement or instrument shall raise the use of a facsimile machine to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile machine as a defense to the formation of a contract, and each such party forever waives any such defense.

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

 

Seller:

Address:

 

By:

/s/ Aram Ervin Kalpakian

 

By:

/s/ Alicia Hurmuzian de Kalpakian

 

By:

/s/ Delfina Isabel Balestra de Kalpakian

 

 

 

Purchaser:

Bain Capital (Europe) LLC
111 Huntington Avenue
Boston, MA  02199
Attention:  Ferdinando Grimaldi

 

By:

Bain Capital Investors, LLC

 

Its:

Manager

 

 

 

By:

/s/ Michael F. Goss

 

Its:

Managing Director

 

 

6


EX-12 3 a05-19976_1ex12.htm INDEMNITY LETTER

Exhibit 12

 

November 14, 2005

 

Samsonite Corporation (“Samsonite”)

11200 East 45th Avenue

Denver, Colorado USA 80239

 

Ares Corporate Opportunities Fund, L.P. (“Ares”)

1999 Avenue of the Stars

Suite 1900

Los Angeles, California USA 90067

 

Bain Capital (Europe) LLC (“Bain”)

111 Huntington Avenue

Boston, Massachusetts USA  02199

 

Ontario Teachers’ Pension Plan Board (“Ontario”)

5650 Yonge Street

Toronto, Ontario, Canada M2M 4H5

 

Dear Sirs,

 

Aram Ervin Kalpakian, Alicia Hurmuzian de Kalpakian, and Delfina Isabel Balestra de Kalpakian (the “Heirs”) hereby declare, represent, and warrant that they are the sole heirs of Daniel Kalpakian (“Daniel”) and that no other person or entity whatsoever is entitled to any inheritance on Daniel’s estate.

 

Reference is hereby made to that purchase agreement entered into on November 14, 2005 by and among Ares, Bain, and Ontario (collectively, the “Purchasers”) and the Heirs concerning the 198 preferred shares of Samsonite’s stock owned by the Heirs as the sole heirs of Daniel’s estate and sold to the Purchasers at a price of US$1,000 liquidation preference for each preferred share plus accrued dividends thereon (the “Purchase Agreement”).

 

Any and all payments to be made in compensation for the sale of the above mentioned stock should be made to us by means of a transfer to the following Bank Account: Northern Trust International Bank; 40 Broad St. l0th floor; ABA 026001122; NYC.NY; UID 140259; Acct 106229-20010; N/O Merrill Lynch; For Sub ac 168-36136; N/O Aram Ervin Kalpakian, Alicia Hurmuzian de Kalpakian, and Delfina Isabel Balestra.

 

The Heirs, jointly and severally, hereby indemnify and hold Samsonite and the Purchasers and each of their general partners, directors, officers, agents, employees, and affiliates and any entity under each of their respective control (the “Indemnified Parties”) harmless against any losses, claims, damages, expenses, or liabilities to any person or entity arising out of or in connection with any breach of a representation or warranty made by the Heirs under the Purchase Agreement, including, but not limited to, any in

 



 

court or out of court claims, any judgments, action, proceeding, investigation, court orders (whether or not awarding compensations or damages), legal costs, expenses and fees that may be incurred or required to be paid by any Purchaser.  Under no circumstance shall the obligation of indemnification provided for herein exceed the aggregate of the purchase price received by the Heirs under the Purchase Agreements.  The Heirs agree with the Purchasers for the benefit of the Purchasers, and for the benefit of all Indemnified Parties, that the reimbursement and indemnity obligations contained herein shall be in addition to any liability which the Indemnified Parties may otherwise have and shall be binding upon and inure to the benefit of any successors and assigns of the Indemnified Parties.

 

The document shall be governed by, and construed in accordance with, the laws of the State of New York without regard to principles of conflict of laws.

 

*              *              *              *              *

 



 

If the foregoing correctly reflects our understanding, please countersign this letter in the space provided below.

 

 

 

Yours truly,

 

 

 

 

 

/s/ Aram Ervin Kalpakian

 

 

Aram Ervin Kalpakian

 

 

 

 

 

/s/ Alicia Hurmuzian de Kalpakian

 

 

Alicia Hurmuzian de Kalpakian

 

 

 

 

 

/s/ Delfina Isabel Balestra de Kalpakian

 

 

Delfina Isabel Balestra de Kalpakian

 



 

Acknowledged by:

 

SAMSONITE CORPORATION

 

By:

/s/ Richard H. Wiley

 

Name:

Richard H. Wiley

Title:

CFO, Secretary and Treasurer

 

ARES CORPORATE OPPORTUNITIES FUND, L.P.

 

By:

/s/ Kevin Frankel

 

Name:

Kevin Frankel

Title:

Vice President

 

BAIN CAPITAL (EUROPE) LLC

 

By:

Bain Capital Investors, LLC

 

Its:

Manager

 

By:

/s/ Michael F. Goss

 

 

Name:

Michael F. Goss

 

Title:

Managing Director

 

ONTARIO TEACHERS’ PENSION PLAN BOARD

 

By:

/s/ Josef Prosperi

 

Name:

Josef Prosperi

Title:

Portfolio Manager

 


-----END PRIVACY-ENHANCED MESSAGE-----